PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 37: Articles 18001-18500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. The effects of recent oral contraceptive use on the outcome of pregnancy.
  2. Efficiency and acceptability of intrauterine contraceptive devices.
  3. Electrophysiological research on uterine and ovarian functions in women using intrauterine coils for contraception. [Elektrofiziologicheskie issledovaniia funktsionalnogo sostoianiia matki i iaichnikov u zhenshchin, primeniaiushchikh v tseliakh kontratseptsii vnutrimatochnye spirali.]
  4. Family planning achievements as suggested by changes of total fertility and party birth rate.
  5. Family planning among health professionals. [Planificacion de la familia en profesionales de la salud.]
  6. Family planning among Nigerian postsecondary female students.
  7. Family planning and abortion among minors: the Spanish case.
  8. Family planning and birth control in Japan.
  9. Family planning and child care.
  10. Family planning and demographic yearbook 1985.
  11. Family planning and diarrheal disease control in primary health care.
  12. Family Planning and Maternal and Child Health for the Indochinese Refugees and Rural Thai People, Thailand-12 Modification No. 9: project description and budget.
  13. Family planning and maternal health care: a common goal: round table.
  14. Family planning and maternal mortality in the Third World [letter]
  15. Family planning and population information activities in Europe: now and in the future.
  16. The family planning and population policies of the government of Burundi. [La politique de la planification familiale en du controle demographique du gouvernement du Burundi.]
  17. Family planning and sex education for young people.
  18. Family planning and the status of women. [Gezinsplanning en de status van de vrouw.]
  19. Family planning as a primary health care activity. [Gezinsplanning als aktiviteit in de primaire gezondheidszorg.]
  20. Family planning as preventive health measure.
  21. Family planning at Nagpur--a sample study.
  22. Family planning attitudes and action.
  23. Family planning awareness in rural Punjab--some suggestions for improving performance.
  24. Family planning clinic services: 1975 - 1985. Summary information from form SBL708 : 1985.
  25. Family planning clinics share blame for men's failure to use services.
  26. Family planning communication in Ghana: retrospect and prospect.
  27. Family planning communication in Ghana: retrospect and prospect.
  28. Family planning communication training needs assessment, Africa region.
  29. Family planning delivery strategies in an industrial setting.
  30. Family planning evaluation methods training for provincial family planning program officials.
  31. A family planning experience. A pilot test--vasectomy services in the city of Leon and surrounding areas--Mexico.
  32. Family Planning for Industrial Workers, INDONESIA-21 Modification No. 10: project description and budget.
  33. Family planning for maternal and child health: an annotated bibliography and resource directory.
  34. Family planning handbook for midwives and nurses. 3rd ed.
  35. Family planning in "maquiladora" plants.
  36. Family planning in a pro-natalist environment: the case of the Bolivian industrial project.
  37. Family planning in California: a demographical overview of "Women in Need".
  38. Family planning in China.
  39. Family planning in INAMPS. [Planejamento familiar no INAMPS.]
  40. Family planning in India, 1969-1984: a district level study.
  41. Family planning in India.
  42. Family planning in India: a critical appraisal.
  43. Family planning in Jordan: 1983 survey data.
  44. Family planning in Nepal from the user's and nonuser's perspectives.
  45. Family planning in Papua New Guinea.
  46. Family planning in Puerto Rico: progress toward the national health goals for 1990, Part 5. [Planificacion familiar en Puerto Rico: progreso hacia los objetivos nacionales de salud para 1990 (V)]
  47. Family planning in the rural governorate of Mahdia. [La planification familiale en milieu rural gouvernorat de Mahdia.]
  48. Family planning increase in some African countries.
  49. Family planning methods: safety, choice and delivery in the primary health care context.
  50. Family planning motivation campaign. The second evaluation study-1985.
  51. Family planning operations research Asia.
  52. Family planning operations research in Asia: final progress report.
  53. Family planning operations research in the Eastern Caribbean (Contract AID/DPE-0632-C-00-2007-00): final report.
  54. Family planning outreach: an operations research study using community health workers and rally posts for family planning outreach in Mirebalais, Haiti.
  55. Family planning pilot projects in Africa: review and synthesis.
  56. Family planning practices among minors in Belgium.
  57. Family Planning Private Sector Programme. Annual report 1985.
  58. Family planning program effectiveness.
  59. A family planning program that pays for itself.
  60. Family planning program: 1985 results. [Programa de planificacion familiar. Resultados 1985.]
  61. Family planning programmes: lessons from management interventions.
  62. Family planning programs.
  63. Family planning promotes social and economic development of Dongguan County.
  64. The family planning rights of minors in Canada: the case of Ontario.
  65. The family planning rights of minors in Czechoslovakia.
  66. The family planning rights of minors in Denmark: contraceptive counselling and sex education.
  67. Family planning rights of minors in Denmark: the legal situation and minors' use of abortion.
  68. The family planning rights of minors in France.
  69. The family planning rights of minors in Hungary.
  70. The family planning rights of minors in Sweden.
  71. Family planning saves lives: a strategy for maternal and child survival.
  72. Family planning services for economically disadvantaged women: utilization, cost and patient satisfaction.
  73. Family planning services in Ireland with particular reference to minors.
  74. Family planning services in rural areas. [Los servicios de planificacion familiar en el medio rural.]
  75. Family planning services to Wisconsin adolescents: matching services provided to client need.
  76. Family planning services: options for Africa.
  77. Family planning survey data from four rural areas in Kenya.
  78. Family planning technical manual for health professionals. 4th ed. [Planification familiale manuel technique pour professionnels de sante.]
  79. A family planning teen parent advocate program.
  80. Family planning under present conditions. [Planiranja porodice u sadasnjim uslovima.]
  81. Family planning within primary health care. [Planificacion familiar en la Atencion Primaria de Salud.]
  82. Family planning work should be brought into the orbit of construction of Socialist spiritual civilization.
  83. Family planning, a facet of social responsibility. Round table on: Family planning and maternal health care: a common goal.
  84. Family planning, maternal mortality, and literacy [letter]
  85. Family planning, nutrition and primary health care for Africa: program design, management, and evaluation: workshop syllabus and schedule, June 2-27, 1986.
  86. Family planning, population, and health in rural Mexico. [Planificacion familiar, poblacion y salud en el Mexico rural.]
  87. Family planning--knowledge, attitudes and practices in the Ejisu-Juaben-Bosomtwe district in the Ashanti region of Ghana.
  88. Family planning. [Aile planlamasi.]
  89. Family planning. [Le planning familial.]
  90. Family planning. Dangers of chasing targets [editorial]
  91. Family planning: needs and costs. Projections, 1985-2000. 15 countries. [Planificacion familiar: necesidades y costos. Proyeccion 1985-2000. 15 paises.]
  92. Family planning: barriers to utilization by adolescent males.
  93. Family planning: beyond contraception.
  94. Family planning: husbands must play their part [letter]
  95. Family planning: men are getting involved.
  96. Family planning: needs and costs projection 1985-2000. [Planificacion familiar: necesidades y costos proyeccion 1985-2000.]
  97. Family planning: the perspective of a Thai public-health worker.
  98. Family planning: the service, the doctor and the patient.
  99. Family size preferences and contraception in Syria.
  100. The family, fertility and contraception in Asia and the Pacific: a review of seven cross-comparative micro-demographic country studies.
  101. Fatty acids in human milk and steroidal contraceptives in Hungary and Thailand.
  102. Female pelvic anatomy: MR assessment of variations during the menstrual cycle and with use of oral contraceptives.
  103. Fertility and family planning in Accra.
  104. Fertility and family planning in Egypt, 1984. Resume and recommendations.
  105. Fertility and family planning in Mauritius.
  106. Fertility and family planning in one region of Senegal.
  107. Fertility and family planning in the Arab region.
  108. Fertility and family planning.
  109. Fertility, family planning, and development: indirect influences.
  110. Fertility, maternal child health and family planning in Lima, 1985. [Fecundidad, salud materno infantil y planificacion familiar en Lima - 1985.]
  111. Fertility, maternal-infant health and family planning in Lima--1985. [Fecundidad, salud materno infantil y planificacion familiar en Lima--1985.]
  112. Fertility, sterility, family planning. Document for physicians, professionals, university level personnel.
  113. The field of family planning: a review and new conceptual framework.
  114. The Filipino male as a target audience in family planning.
  115. Final report: "Alternatives to Expand Family Planning Services in Brazil: Seminar on Operations Research and Methodology", ABEPF (Associacao Brasileira de Entidades de Planejamento Familiar). Contract No. CI85.34A, February 1, 1986 - April 30, 1986.
  116. Final report: a systematic evaluation of family life education on contraceptive use and pregnancy among teens.
  117. First end the exploitation of peasant women. Round table on: Family planning and maternal health care: a common goal.
  118. First human trial of a contraceptive vaccine. [Premiere experimentation humaine d'un vaccin contraceptif.]
  119. First male contraceptive on horizon?
  120. First National Contraceptive Prevalence Survey [MRDF]] [Primera Encuesta Nacional de Prevalencia de Anticonceptivos.]
  121. First premarital contraceptive use: United States, 1960's-1982.
  122. Folk media and the promotion of family planning information.
  123. Folklore herbal contraceptives and remedies.
  124. Follow-up study of fertility after the use of contraceptive tablets.
  125. Footnotes to a history of the family planning program in Indonesia: the beginnings.
  126. Frequency and adequacy of use of contraceptive methods by women of Campinas. [Frequencia e adequacao no uso de metodos contraceptivos por mulheres de Campinas.]
  127. Future implications of alternative family planning policies in China.
  128. The future of male birth control.
  129. The future prospects of the national family planning program in Indonesia: the introduction of Norplant in Indonesia.
  130. Ghana Social Marketing Programme contraceptive and family planning training manual.
  131. Good news about contraceptives and PID.
  132. Gossypol: a male contraceptive with potential?
  133. A grand gathering of model family planning workers in China.
  134. Guide for training in the psychosocial aspects of family planning. [Guide pour la formation aux aspects psycho-sociaux de la planification familiale.]
  135. Guidelines for operations research in family planning programs.
  136. Gynaecological and sexuality profile of new patients attending a family planning clinic.
  137. Harijans and Girijans of Andhra Pradesh: an application of analysis of variance in the study of fertility, mortality and family planning.
  138. Hazardous contraceptive [letter]
  139. HCG immunisation for contraception.
  140. Health and family planning in Africa.
  141. Health and family planning program in Jalisco state. [Salud y planificacion familiar programa en el estado de Jalisco.]
  142. Health care and birth control in Indonesia: links through time.
  143. Health care not the only target for family planning. Round table on: Family planning and maternal health care: a common goal.
  144. A health perspective of hormonal contraceptives.
  145. Hemolytic and uremic syndrome following oral contraception. [Syndrome hemolytique et uremique au decours d'une contraception orale.]
  146. Hepatocellular adenoma related to oral contraceptive use; report of two cases.
  147. Hepatotoxicity of oral contraceptives.
  148. Herbal contraceptives: exploring indigenous methods of family planning.
  149. Histochemical and immunohistochemical detection of putative preneoplastic liver foci in women after long-term use of oral contraceptives.
  150. Histologic lesions caused by use of oral contraceptives. [Lesioni istologiche da uso di anticoncezionali orali.]
  151. Historical survey of modern reversible contraceptive methods. [Apercu historique sur les methodes contraceptives modernes reversibles.]
  152. History and politics of planned parenthood laws in Poland.
  153. History of the development of planned parenthood as a basic human right in Yugoslavia.
  154. A holistic approach to family planning counseling and education.
  155. Honduras: survey of purchasers of oral contraceptives. Subcontract.
  156. Hormonal contraception and cancer.
  157. Hormonal contraception. [Anticoncepcion hormonal.]
  158. Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases. [Gormonalnye protivozachatochnye sredstva kak faktor riska dlia vozniknoveniia ostrykh tromboembolicheskikh zabolevanii.]
  159. How Planned Parenthood got its name.
  160. Hysteroscopic treatment of early pregnancy conceived despite intrauterine contraception.
  161. The Ibadan Market-Based Health/Family Planning Project. Phase I process research: analysis of market agent characteristics and performance in service delivery.
  162. ICMR Task Force Study on Hormonal Contraception: biological activity of ethinyl estradiol present in the breast milk.
  163. Identical twinning and oral contraception.
  164. Identification of groups of maternal risk among users of contraceptive methods in Trujillo 1984. [Identificacion de grupos de riesgo materno en usuarias de metodos anticonceptivos en Trujillo 1984.]
  165. The IEC management of the National Family Planning Program.
  166. Immunogenetic considerations in the development of contraceptive vaccines based on testicular or sperm antigens.
  167. Immunogenicity trial of a contraceptive vaccine based on human chorionic gonadotrophin.
  168. Immunologic properties of LDH-C4 for contraceptive vaccine development.
  169. Immunological approaches to contraception: the need, basic premise, and overview.
  170. Immunological methods of birth control. [Immunologicheskie metody reguliatsii rozhdaemosti.]
  171. Impact and efficiency of family planning programme in Korea (ESCAP Support)
  172. Impact of home visits by nurses and village motivators on family planning services in rural Egypt, [Health Services Research Group, ECTOR, Institute of National Planning, Egypt]. Operations research project summary.
  173. Impact of hormonal contraceptives vis-a-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives.
  174. Impact of integrated family planning clinics on acceptance and continuation in a rural area of Kenya (Phase I), [Nairobi Center for Research in Reproduction]. Operations research project summary.
  175. Impact of integration on family planning with MCH and other development programmes: an action oriented project, Phase I, Pakistan, [National Institute of Fertility Control, Pakistan]. Operations research project summary.
  176. The impact of sex education on sexual activity, contraceptive use and premarital pregnancy among American teenagers.
  177. The implementation of contraceptive counselling services as a strategy to induce contraceptive use.
  178. Implementation of vasectomy services in family planning integrated and non-integrated clinics. AID/Brazil: PIN 023-2. Project description.
  179. An incentives program to increase contraceptive prevalence in rural Thailand.
  180. Incidence of repeat abortion, second trimester abortion, contraceptive use, and illness within a teenage population.
  181. Increased nevus estrogen and progesterone ligand binding related to oral contraceptives or pregnancy.
  182. Increased risk for genital infection with Chlamydia trachomatis in a cohort of women using oral contraception.
  183. Incrustation of indicating threads of intrauterine contraceptive devices in uterine cavity and cervix. [Inkrustation der Markierungsfaden von Intrauterinpessaren im Cavum und der Cervix uteri.]
  184. The Indonesian Family Planning Program. Information, education and communication strategy for family planning: the Indonesian experiences.
  185. The Indonesian family planning program: government influence and client choice.
  186. The Indonesian National Family Planning Program.
  187. Inequalities in preventive health care: birth control provision in Britain.
  188. The infant and the quality of life in Madagascar: a consideration for a family planning policy. [L'enfant et la qualite de la vie a Madagascar consideration pour une politique de planification familiale.]
  189. Infant feeding in Metro Manila: infant feeding decisions, infant health and family planning among low income families.
  190. Infertility in relation to prior contraceptive use.
  191. Inflammatory bowel disease and oral contraception. [Entzundliche Darmerkrankungen und hormonelle Antikonzeption.]
  192. Inflammatory bowel disease in oral contraceptive users [letter]
  193. The influence of age at marriage on fertility and family planning behaviour: a cross-cultural study.
  194. Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid.
  195. Influence of hormonal contraceptive agents on pregnancy, lactation, and return of fertility. [Einfluss hormonaler Kontrazeptiva auf Schwangerschaft, Laktation und Ruckkehr der Fertilitat.]
  196. The influence of hormonal contraceptives on tear film stability. [Zur Beeinflussung der Tranenfilmaufreisszeit durch hormonale Kontrazeptiva.]
  197. The influence of planned parenthood on the health and development of the people. [Seminar: De invloed van verantwoord ouderschap op de gezondheid en ontwikkeling van de bevolking.]
  198. Influence of socially shared traditional beliefs on contraceptive behavior. [Influence des schemas culturels traditionnels sur le choix de la contraception.]
  199. The influence of the contraceptive pill on feeding patterns in young women.
  200. The influence of the health care system on contraceptive use and breastfeeding in rural Mexico.
  201. An information component for the proposed USAID private sector health and family planning project: what is needed, what is available, how might it be organized?
  202. Inhibin and gonadal parahormones: possible contraceptive agents.
  203. Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycle.
  204. The initiation of postpartum contraception in Thailand: results from the 1984 Contraceptive Prevalence Survey.
  205. Injectable contraceptive: further considerations.
  206. Injectable contraceptive: nuclear effects after use. [Anticoncepcional injetavel: modificacoes nucleares apos o uso.]
  207. Injectable contraceptives in developing countries [letter]
  208. Injectable contraceptives in developing countries.
  209. Injectable contraceptives in developing countries. Reply to letter of Sumati Nair [letter]
  210. Injectable contraceptives in mass programme; alarming scope for misuse.
  211. Injectable contraceptives: how safe is safe?
  212. Integrated family planning and health care in marginal urban areas, Peru (Phase I). [Universidad Peruana Cayetano Heredia] Operations research project summary.
  213. Integrated family planning and parasite control project in Oeiras and Rio de Janeiro. [Proyecto integrado de planeacion familiar y control de parasitos intestinales en Oeiras y Rio de Janeiro.]
  214. Integrating a family planning program with a county health department based maternal and child health program.
  215. The integration into the university curriculum of student practice in family planning. [Integracion a la curricula universitaria de practicas estudiantiles en planificacion familiar.]
  216. Integration of midwives of rural areas in family planning. [La integracion de matronas del area rural en la planificacion familiar.]
  217. Interactions between oral contraceptive steroids and broad-spectrum antibiotics.
  218. Interactions of drugs with oral contraceptives. [Wechselwirkung von Medikamenten mit oralen Kontrazeptiva.]
  219. Intercountry consultative meeting on recent advances in contraceptive technology, National Institute of Health and Family Welfare (NIH and FW) New Delhi, 1-5 December 1986.
  220. International family-planning training for nurse practitioners.
  221. Intestinal ischemia and infarction associated with oral contraceptives.
  222. The intrauterine contraceptive device and hydatidiform mole: a negative association.
  223. Intrauterine contraceptive devices [letter]
  224. Introducing and improving family planning services in Africa through operations research.
  225. Introducing new contraceptives.

     

  226. Introduction of a promotional package on the use of combinations of methods to improve contraceptive effectiveness. Final report.
  227. Inventory of selected local family planning experiences in countries of the ESCAP Region [volume 8]
  228. Involve the general public, especially the young. Round table on: Family planning and maternal health care: a common goal.
  229. The involvement of the government of the Eastern Caribbean states in family planning activities. [De betrokkenheid van de overheid m.b.t. family planning in de Oost-Caraibische staten.]
  230. Involving young men in family planning services.
  231. Iron stores in users of oral and intrauterine contraception.
  232. Is it early or long-term use of birth control pills that increases risk of breast cancer? [Ar det tidig eller langvarig anvandning av p-piller som ger okad risk for brostcancer?]
  233. Is the malpractice crisis filtering down to family planning?
  234. Isotretinoin and contraception [letter]
  235. Issues in family planning training in the Eastern Caribbean: experiences from one project.
  236. Jane Hodgson, M.D.; Arthur Horowitz, M.D.; Michelle Roe, Alice Roe, Diana Roe, Nadine T., Janet T., and Ellen Z. individually and on behalf of all other persons similarly situated; Lauren Z.; Meadowbrook Women's Clinic, P.A., Planned Parenthood of Minnesota, a nonprofit Minnesota corporation, Midwest Health Center for Women, P.A., a nonprofit Minnesota corporation; Women's Health Center of Duluth, P.A., a nonprofit Minnesota corporation, Plaintiffs, v. The State of Minnesota; Rudy Perpich, as Governor of the State of Minnesota; Hubert H. Humphrey, III, as Attorney General of the State of Minnesota, Defendants. Findings of Fact, Conclusions of Law and Order.
  237. Japan's fertility: effects of contraception and induced abortion after World War II.
  238. Japan's long wait for modern contraception.
  239. Just for boys--a social approach to sex education and family planning.
  240. KB-Gizi--an Indonesian integrated family planning, nutrition and health program: the evaluation of the first five years of program implementation in east Java and Bali.
  241. Kenya contraceptive prevalence survey 1984, provincial report.
  242. Kenya Contraceptive Prevalence Survey [MRDF]
  243. Knowledge and opinion of unmarried college girls about family planning.
  244. Knowledge and practice of community contraceptive distributors in Honduras. [Conocimientos y practicas de las distribuidoras comunitarias de anticonceptivos en Honduras.]
  245. Knowledge and utilization of health and family planning services in Gujarat.
  246. Knowledge of family planning methods in Bangladesh, 1969-1979: trends and implications.
  247. Laparoscopic female sterilization--an evaluation exercise in a Malaysian family planning clinic.
  248. The learning process approach in family planning program development. Concept paper.
  249. The legal and ethical status of female voluntary surgical contraception in Brazil.
  250. The legal and factual status of planned parenthood in France.
  251. Levonorgestrel concentrations in maternal and infant serum during use of subdermal levonorgestrel contraceptive implants, Norplant by nursing mothers.
  252. LHRH agonist and contraception.
  253. Life styles, contraception and parenthood. [Relatievormen, anticonceptie en ouderschap.]
  254. Life-table methods for contraceptive research.
  255. Light induced reactions of contraceptive steroids.
  256. Lipids, lipoproteins, arterial accidents and oral contraceptives. [Lipides, lipoproteines, accidents arteriels et contraceptifs oraux.]
  257. Literacy, parity, family planning, and maternal mortality in the Third World. [Reply to Labbok letter]
  258. Liver cancer and long-term use of oral contraceptives.
  259. Liver parameters during administration of a combined contraceptive pill and its components.
  260. Local initiative to provide family planning in Juba Town, southern Sudan.
  261. Locally acting contraceptives. [La contraception locale.]
  262. Long-acting contraceptive steroids and interception.
  263. Long-term contraception methods] [Reply to question of H. Mehnert. [Langfristige kontrazeption.]
  264. Long-term follow-up of children breast-fed by mothers using oral contraceptives.
  265. Long-term use of oral contraceptives and risk of invasive cervical cancer.
  266. Longevity of Ortho Creme and Gynol II in the contraceptive diaphragm.
  267. Longterm use of the Today contraceptive sponge.
  268. Lost intrauterine contraceptive device removed by proctoscopy.
  269. Low-dose oral contraceptives: progestin potency, androgenicity, and atherogenic potential.
  270. Luliberin analogs--a new class of contraceptive agents. [Analogi liuliberina--novy i klass kontratseptivnykh sredstv.]
  271. Luteinizing hormone releasing hormone (LHRH): II. A new contraceptive agent.
  272. Maintaining family planning acceptance levels through development incentives in Northeastern Thailand.
  273. Male contraception in family planning programs.
  274. Male contraception. [Mandlig kontraception.]
  275. Male promotion for family planning in Dominica.
  276. The mammographic breast pattern and oral contraception.
  277. Management and delivery of contraceptive in China.
  278. Management evaluation of the Zimbabwe National Family Planning Council.
  279. Management information systems and their suitability to family planning clinics: questions needing answers.
  280. Management of translocated and incarcerated intrauterine contraceptive devices.
  281. Margaret Sanger and the birth control movement: a bibliography, 1911-1984.
  282. Marketing family planning in Nepal: a study of consumers and retailers.
  283. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
  284. Maternal and child health and family planning services.
  285. Maternal-Child Health and Family Planning Survey, Honduras, 1984, final report.
  286. Maternal-Child Health/Family Planning Survey, Panama 1984: English language report.
  287. Maternal-infant protection. Family planning and nutrition. Annual report 1985. [Protection materno infantile. Planification familiale et nutrition. Rapport annuel annee 1985.]
  288. The Matlab Family-Planning Health Service Project. Impact on family planning, fertility and child survival: an executive summary of a report of key findings and their policy implications.
  289. Measuring the prevalence of contraceptive use: a family planning program evaluation guide.
  290. Mechanism of contraceptive effect of triterpene glycosides of androsace-septentrionalis. [K mekhanizmu protivozachatochnogo deistviia triterpenovykh glikozidov prolomnika severnogo.]
  291. Medico-social aspects of contraception (editorial) [Aspectos medico-sociais da contracepcao.]
  292. Men and women together: the impact of birth control technology on male-female relationships.
  293. Men Too--a retrospective view of the Family Planning Association's male responsibility campaign.
  294. Menstrual changes associated with progestogen-only contraception.
  295. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
  296. Metabolic effects of oral contraceptives: a panel discussion.
  297. Methodology for a survey of knowledge, attitudes and practices of the population in matters of family planning in Rwanda. Vol 1]
  298. Methods of birth control.
  299. Migrants and their special needs in relation to sexuality and family planning in Belgium.
  300. Migrants and their special needs in relation to sexuality and family planning in the Federal Republic of Germany.
  301. Mini contraceptive prevalence survey, 1984.
  302. Minimizing the metabolic risks of oral contraceptives through patient counseling and monitoring.
  303. Minister Wang Wei on family planning policy and population aging.
  304. The missing ingredient: involving young men in family planning. Conference Report.
  305. Mitral valve prolapse in women with oral contraceptive-related cerebrovascular insufficiency: associated persistent hypercoagulable state.
  306. Mobilizing satisfied users for promoting family planning: final report on a pilot study in the eastern Visayas region of the Philippines.
  307. Modern aspects of contraception. [Moderne Aspekte der Kontrazeption.]
  308. Modern contraceptive practice in rural Appalachia.
  309. Modern methods of contraception in the USSR. A review.
  310. Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives.
  311. More women shopping for birth control items. Disease fears cause condom sales increase.
  312. Nigeria: community-based family planning.
  313. Nigerian airwaves call for family planning.
  314. The non-physician provision of clinical family planning in Seoul, Korea, [Seoul National University, Institute of Reproductive Medicine and Population and Dobong Gu Health Centre]. Operations research project summary.
  315. Nonsteroidal contraception -- alternatives to the pill.
  316. The NORPLANT contraceptive system.
  317. Norplant, subdermal contraceptive implant. [Norplant--subdermalni kontraceptivni implantat.]
  318. Nurse's involvement in family planning: need and significance of training and orientation.
  319. Nutrition within a family planning clinic.
  320. Observational studies of cause-effect relationships: an analysis of methodologic problems as illustrated by the conflicting data for the role of oral contraceptives in the etiology of rheumatoid arthritis.
  321. Observations with Anteovin "step-up" contraceptive tablet in young women.
  322. Occult perforation of the uterus by an intrauterine contraceptive device. [Okkulte Uterusperforation durch Intrauterinpessar.]
  323. ODA-supported research into family planning communication: positive results boosting programme in Asia and Africa.
  324. Ombrelle 250: a new contraceptive intrauterine device. [L'Ombrelle 250: un nouveau dispositif intra-uterin contraceptif.]
  325. On China's family planning policy.
  326. On clinical judgment: modeling physicians' recommendations of contraceptives.
  327. One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.
  328. One-year results using a risk scoring system in a family planning clinic.
  329. Operations research to improve access to and continuation of family planning through community-based outreach in Cite Simone, an urban slum of Port-au-Prince, Haiti.
  330. Operations research to test alternative strategies for providing sex education and family planning services to young adults in Mexico.
  331. Oral and intrauterine contraception: assignment of characteristics and perceptions among present users, ex-users, and nonusers in Flanders. [De hormonale- en de intra-uteriene anticonceptie. Eigenschapstoekenning en beeldvorming bij huidige-, ex- en nooit-gebruiksters in Vlaanderen.]
  332. Oral contraception and carbohydrate metabolism: III--practical implications. [Contraception orale et metabolisme glucidique III--implications pratiques.]
  333. Oral contraception and hormone replacement therapy: are progestogens and progestins breast nitrogens? [letter]
  334. Oral contraception and thrombosis: implication of anti sex-steroid hormone antibodies.
  335. Oral contraception with a biphasic tablet (observations with Anteovin)
  336. Oral contraception, ovarian disorders and tobacco in myocardial infarction of woman.
  337. Oral contraception. Common problem protocol.
  338. Oral contraception: hormonal influences on blood pressure.
  339. Oral contraceptive agents and arterial hypertension. [Peroralni kontratseptivni sredstva i arterialna khipertoniia.]
  340. Oral contraceptive agents.
  341. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway.
  342. Oral contraceptive use and the risk of breast cancer in women with a "prior" history of benign breast disease.
  343. Oral contraceptives -- an overview.
  344. Oral contraceptives -- the long-term perspective.
  345. Oral contraceptives and blood coagulation.
  346. Oral contraceptives and breast cancer [letter]
  347. Oral contraceptives and breast cancer [letter]
  348. Oral contraceptives and breast cancer in young women [letter]
  349. Oral contraceptives and breast cancer in young women: some notes on a current controversy.
  350. Oral contraceptives and breast cancer.
  351. Oral contraceptives and breast cancer.
  352. Oral contraceptives and breast cancer: a national study.
  353. Oral contraceptives and breast cancer: a prospective cohort study.
  354. Oral contraceptives and cancer: review.
  355. Oral contraceptives and cardiovascular diseases morbidity. [Anticonceptivos orales y morbilidad de enfermedades cardiovasculares.]
  356. Oral contraceptives and cervical neoplasia: pooled information from retrospective and prospective epidemiologic studies.
  357. Oral contraceptives and Chlamydia infections [letter]

     

  358. Oral contraceptives and Chlamydia infections. In reply [letter]
  359. Oral contraceptives and Crohn's disease [letter]
  360. Oral contraceptives and griseofulvin interaction [letter]
  361. Oral contraceptives and hepatocellular carcinoma [letter]
  362. Oral contraceptives and hepatocellular carcinoma [letter]
  363. Oral contraceptives and hepatocellular carcinoma [letter]
  364. Oral contraceptives and hepatocellular carcinoma.
  365. Oral contraceptives and life expectancy.
  366. Oral contraceptives and lipoprotein metabolism.
  367. Oral contraceptives and metabolic changes. [Anticonceptivos orales y alteraciones metabolicas.]
  368. Oral contraceptives and migraine headaches. [Answer to question of Dale B. Sherrod]
  369. Oral contraceptives and migraine headaches. [Answer to question of Dale B. Sherrod]
  370. Oral contraceptives and other risk factors for gallbladder disease.
  371. Oral contraceptives and rheumatic diseases. [Contraceptifs oraux et maladies rhumatismales.]
  372. Oral contraceptives and stroke: a preliminary report on an epidemiologic study in Taiwan, China.
  373. Oral contraceptives and the eye. [Oralnye kontratseptivy i organ zreniia]]
  374. Oral contraceptives and the occurrence of disease. Clinical overview.
  375. Oral contraceptives and thromboembolic disease [editorial]
  376. Oral contraceptives and venous thromboembolism: findings in a large prospective study.
  377. Oral contraceptives in a Southern Italian community.
  378. Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles.
  379. Oral contraceptives in epilepsy.
  380. Oral contraceptives--time to take stock [editorial]
  381. Oral contraceptives: assessment of benefits.
  382. Oral steroid contraceptives.
  383. Oral-contraceptive use and the risk of breast cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development.
  384. Organon contribution to family planning, 3rd ed.
  385. Otolaryngological side effects of oral contraceptives. [Dzialania uboczne w zakresie otolaryngologii po doustnych srodkach antykoncepcyjnych.]
  386. Overall evaluation of the Korean National Family Planning Program.
  387. Overview of controlled release systems for male contraception.
  388. An overview of injectable contraceptives with special application to Bangladesh.
  389. Panel discussion: family planning. [Panel: aile planlamasi.]
  390. Paper on sterilization in the family planning programs of Colombia: a national debate. [El papel de la esterlizacion en los programas de planificacion familiar de Colombia: un debate nacional.]
  391. The paramedicalization of family planning services in Morocco.
  392. Parity, related sociodemographic factors and contraceptive use in Saudi Arabia.
  393. Partners in Health. Sexuality: contraceptive and reproductive health issues.
  394. Pelvic inflammatory disease and contraceptive practice.
  395. Pelvic inflammatory disease and oral contraceptive use.
  396. Peptide contraception by inhibition of ovulation with intranasal GnRH superagonist: clinical and metabolic aspects.
  397. Perceptions of adolescent females on contraception in Botswana.
  398. Perforation of sigmoid colon by an intrauterine contraceptive device.
  399. Performance of supply-oriented family planning policy in Bangladesh: an examination.
  400. Pharmacists and family planning. First National Conference on Pharmacists and Family Planning. 18-19 January 1986.
  401. Pharmacokinetics of contraceptive steroids in humans.
  402. Physician attitudes and family planning in Nigeria.
  403. Physician extender services in family planning agencies: issues in Medicaid reimbursement.
  404. Physicians' views of natural family planning: four country study.
  405. The pill, smoking and inflammatory bowel disease - results from the Royal College of General Practitioners (RCGP) Oral Contraception Study [abstract]
  406. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
  407. A plan to assess the utility of pictorial print materials in providing method-specific information and support for contraceptive continuation. Evaluation sites: Botswana, Sierra Leone.
  408. Planned parenthood in Europe: a human rights perspective.
  409. Planned parenthood in the context of human rights.
  410. Planned parenthood legislation and practice in Belgium.
  411. Poor women, powerful men: America's great experiment in family planning.
  412. The Pope and the new apocalypse: the holy war against family planning.
  413. Popularization of contraception. [Populiarizatsiia Kontratseptsii.]
  414. Population and family planning (1975-1983)
  415. Population and family planning in Thailand.
  416. Population growth, economic development and family planning.
  417. Population policy and family planning.
  418. Population problem and planned parenthood.
  419. Population, family planning and primary health care plans, strategies and programs of PAHO/WHO. [Poblacion, planificacion familiar y atencion primaria de salud planes, estrategias y programas de la OPS/OMS.]
  420. Population, family planning and primary health care. [Poblacion, planeacion familiar y atencion primaria de la salud.]
  421. Post coital contraception.
  422. Post-marketing surveillance of oral contraceptives.
  423. Post-Partum/Family Planning Service--Belem. Brazil-04 modification 14. Project description and budget. [Excerpts]
  424. Postcoital contraception.
  425. Postcoital contraception. [Postkoitalna antikoncepcia.]
  426. Postpartum and postabortion contraception. [Anticoncepcion posparto y postaborto.]
  427. Postpartum sexuality and contraception.
  428. Potential application of inhibin in male and female contraception.
  429. The practical aspects of clinical trials of contraceptive methods.
  430. Predictors of contraceptive use among women in Kuala Lumpur and Petaling Jaya.
  431. Pregnancy after contraceptive use.
  432. Pregnancy, birth and family planning.
  433. Preliminary achievements of China's national economy development and family planning.
  434. Preliminary comments from CSAC on MP Vessey's paper on Return of fertility after discontinuation of oral contraceptives: influence of age and parity [letter]
  435. Preliminary data from Nyahururu Natural Family Planning Project.
  436. Preliminary report: findings from Nepal Fertility and Family Planning Survey, 1986.
  437. Presence of daughters-in-law in the household: a good contraceptive.
  438. Presentation of a survey of attitudes towards family planning and family planning information sources.
  439. Press conference on the "Mr Able" family planning campaign. Press release.
  440. Prevalence of Chlamydia trachomatis in women attending a family planning clinic: the need for a screening service.
  441. Prevalence of contraceptive use in developing countries: a chart book.
  442. Prevention of contraceptive failure--an overview.
  443. Prevention of contraceptive failures with hormonal implants.
  444. Prevention of maternal deaths in developing countries: how much could family planning help?
  445. Primary health care and family planning operations research in church-sponsored community programs in Kenya.
  446. Principal decisional factors relating to contraceptive usage in adolescents. [Les principaux facteurs decisionnels relatifs a l'utilisation contraceptive chez des adolescentes.]
  447. The private sector approach to family planning in Kenya.
  448. Private Sector Family Planning Project. Project Description and Budget.
  449. PRO-PATER Survey. Level of information, use, counseling and practice of family planning by the physicians of Sao Paulo, Brazil. [Pesquisa PRO-PATER. Nivel de informacao, uso, aconselhamento e pratica de planejamento familiar por medicos de Sao Paulo, Brazil.]
  450. The problem of birth control in schizophrenic patients.
  451. Procedures for improving follow-up in contraceptive clinical trials: the Sri Lanka experience.
  452. Proceedings of the Nineteenth Annual Conference, Association for Population/Family Planning Libraries and Information Centers--International. Applying information technology in small libraries.
  453. Profamilia and family planning. [Profamilia y la planeacion familiar.]
  454. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
  455. Program for the promotion of lactation and family planning in Honduras.
  456. Project description and budget. Project number: Brazil-19. Project title: Integrated Community-Based Family Planning and Health Care Program in the State of Paraiba.
  457. Project description and budget. Project number: Burkina-01/Modification 3. Project title: High Risk and Family Planning Clini c.
  458. Project on family planning among the Senegalese: preliminary report. [Projet sur la planification familiale chez les Senegalais: rapport preliminaire.]
  459. A projection of family planning needs and costs 1985-2000: Barbados.
  460. A projection of family planning needs and costs 1985-2000: Belize.
  461. A projection of family planning needs and costs 1985-2000: Bolivia.
  462. A projection of family planning needs and costs 1985-2000: Colombia.
  463. A projection of family planning needs and costs 1985-2000: Costa Rica.
  464. A projection of family planning needs and costs 1985-2000: Dominican Republic.
  465. A projection of family planning needs and costs 1985-2000: Ecuador.
  466. A projection of family planning needs and costs 1985-2000: El Salvador.
  467. A projection of family planning needs and costs 1985-2000: Guatemala.
  468. A projection of family planning needs and costs 1985-2000: Haiti.
  469. A projection of family planning needs and costs 1985-2000: Honduras.
  470. A projection of family planning needs and costs 1985-2000: Jamaica.
  471. A projection of family planning needs and costs 1985-2000: Panama.
  472. A projection of family planning needs and costs 1985-2000: Paraguay.
  473. A projection of family planning needs and costs 1985-2000: Peru.
  474. Proliferative changes occurring in cervical and uterine mucosa in intrauterine contraceptive users. [Proliferativnye izmeneniia slizistoi obolochki tela i sheiki matki u zhenshchin, primeniaiushchikh vnutrimatochnye kontratseptivy.]
  475. Promoting family planning through village level meetings and volunteer workers in southern Thailand.
  476. Promoting family planning through women's development.
  477. Prospects and problems of integration of family planning with health services in Bangladesh.
  478. Prospects of a male contraceptive based on the selective antispermatogenic action of 1,2,3-trihydroxypropane (THP, glycerol)
  479. Prostanoid mediated effects of centchroman, a non-steroidal oral contraceptive.
  480. Providing quality family planning and MCH services in the urban areas: the YKB experience.
  481. Providing technical assistance to family planning organizations in the United States: lessons learned.
  482. Provision by non-physicians of family planning care in rural areas of Egypt, [Egypt Department of Health, Egypt Family Planning Board, Mabarrah Hospital]. Operations research project summary.
  483. Provision by non-physicians of family planning care in rural Philippines, [Philippines Ministry of Health, National Family Planning Office]. Operations Research Project summary.
  484. The provision of contraception to teenagers and university students.
  485. Provision of family planning care by non-physicians in Cubuk District, Turkey, [Hacettepe University, Department of Public Health]. Operations research project summary.
  486. Psychosocial aspects of contraceptive use.
  487. Public policy and public opinion toward sex education and birth control for teenagers.
  488. Publicity and education on family planning information in Keshan County.
  489. Putting family planning on the air in Africa.
  490. Rationale for a new triphasic oral contraceptive.
  491. Reasons for beginning and giving up contraception among adolescents. [Motivazioni di inizio e sospensione della contraccezione nelle adolescenti.]
  492. Recent contraceptive behavior of young Quebecois women. [Comportement recent des jeunes quebecoises en matieres de contraception.]
  493. Regional Workshop on Innovative Approaches to Maternal and Child Health and Family Planning. Convened by the Regional Office for the Western Pacific of the World Health Organization, Manila, Philippines, 22-26 September 1986. Report.
  494. The regulation of sexuality: experiences of family planning workers.
  495. The relationship between intrauterine contraception and ectopic pregnancy. [K otazce vztahu nitrodelozni antikoncepce a mimodelozniho tehotenstvi.]
  496. Relationship between urinary tract infection and contraceptive methods.
  497. The relationship of family planning nurse and client.
  498. The relationship of locus control and contraception use in the adolescent population.
  499. Relationship of migraine headache and stroke to oral contraceptive use.
  500. Removal of an intra-uterine contraceptive device per rectum.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.